ContraFect Corporation

More Than The Placebo Effect When I moved to the commercial side of a big pharmaceutical company, one of the first things I did was to read through all the promotional copy and labels for my product,

While ContraFect Corporation. ’s exebacase may still have a viable clinical development pathway, the company has found its overall clinical development program knocked back several places after a dec

Biopharmaceutical companies have launched 26 initial public offerings in the US this year as of the start of the week, including four offerings that priced on 18 March and raised $678.8m for Instil B

Business is booming for drug developers – including for those who aren’t working on vaccines or therapeutics against COVID-19 – so investors continue to invest massive amounts of money in public bioph